A New Immunotherapy Combination for Metastatic Pancreatic Cancer
Researchers are looking at a combination of two types of monoclonal antibodies to treat advanced pancreatic cancer.
Researchers are looking at a combination of two types of monoclonal antibodies to treat advanced pancreatic cancer.
Researchers are conducting a phase 0 study of a new drug that may cause inflammation to stimulate immune system against cancer.
When Dennis Rues’s pancreatic cancer recurred, his doctors recommended that he join a clinical trial. Now he’s doing well.
A platform clinical trial evaluates immunotherapy combinations with standard of care treatment for advanced pancreatic cancer.
Because Helene Avraham-Katz has the BRCA2 mutation, certain chemotherapies work better and she is eligible for specific clinical trials.
Dr. Lewis Cantley discusses the latest research on and clinical trials of vitamin C for KRAS-mutated and pancreatic cancer.
A clinical trial tests an investigational drug, immunotherapy, and radiation in combination against advanced pancreatic cancer.
Dr. Shubham Pant is focusing his research on effective treatments for the KRAS mutation, found in 90% of pancreatic cancers.
Dr. Philip Philip focuses on disrupting cancer cell metabolism with devimistat, now in a phase III global clinical trial.
Bob Minetti and his doctors believe that a clinical trial saved his life after a pancreatic cancer diagnosis.